The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement

Author： Poggesi Italo   Snoeys Jan   Van Peer Achiel  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.10, Iss.5, 2014-05, pp. : 631-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Physiologically Based Pharmacokinetic Modeling of Arsenic in the Mouse

By Gentry P. Robinan   Covington Tammie   Mann Sabine   Shipp Annette   Yager Janice   Clewell Harvey  

Journal of Toxicology and Environmental Health, Vol. 67, Iss. 1, 2004-06 ,pp. : 43-71

Taylor & Francis Ltd

Access to resources Recommend Favorite

Physiologically-based pharmacokinetic modeling of pyrene in the rat

By Haddad S.   Withey J.   Lapare S.   Law F.   Krishnan K.  

Environmental Toxicology and Pharmacology, Vol. 5, Iss. 4, 1998-06 ,pp. : 245-255

Elsevier

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic Modeling of a Homologous Series of Barbiturates in the Rat: A Sensitivity Analysis

By Nestorov Ivan A.   Aarons Leon J.   Rowland Malcolm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 4, 1997-08 ,pp. : 413-447

Springer Publishing Company

Access to resources Recommend Favorite

Integration of Physiologically‐Based Pharmacokinetic Modeling into Early Clinical Development: An Investigation of the Pharmacokinetic Nonlinearity

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 5, 2015-05 ,pp. : 286-294

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human pharmacokinetic profiling of the dipeptidyl peptidase‐IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 3, 2015-04 ,pp. : 148-162

John Wiley & Sons Inc

Access to resources Recommend Favorite